1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH Opsumit 10 Mg Tablet - Interstitial Lung Disease, Scleroderma | Phase 2 / Phase 3 | Withdrawn | Franz Rischard, DO | 2018-09-01 | 2025-02-20 |
Hypertension, Pulmonary (1) · Lung Diseases, Interstitial (1)
Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Hypertension (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Scleroderma, Systemic (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Vascular Diseases (1)
Tablets (1) · macitentan (1)
United States (1)